EUVIMED · CrossrefZeitschrift
Expert Review of Vaccines
ISSN 1476-0584 · Informa UK Limited
Neueste Artikel
Pneumococcal conjugate vaccines in older adults and immunocompromised individuals
A human Lyme disease vaccine: two steps forward on the path to prevention
Vaccines preventing neonatal sepsis: focus on Group B Streptococcus , Klebsiella pneumoniae and Escherichia coli to combat rising antimicrobial resistance
Addressing RSV infection in older adults: implications for public health policy
Epidemiological shifts in coxsackievirus A-induced hand, foot, and mouth disease in China, 2008–2024
Evaluation of varicella outbreak control following implementation of a two-dose free vaccination policy in Wuxi, China (2014–2024)
From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virus
Recent advances for the pharmaceutical production of highly attenuated poxviruses as viral vector platforms
Effectiveness and implementation of electronic decision support for adult vaccination in primary care: a mixed-methods quasi-experimental evaluation
Modeling the cost-effectiveness of NVX-CoV2705 and the public health impact of vaccination for the prevention of seasonal COVID-19 in the US
Testing a 24-valent pneumococcal investigational vaccine in older adults aged 65 to 85 years: safety, reactogenicity, and immunogenicity. A plain language summary of two publications
Progress toward HIV-1 subtype C vaccines: understanding antiviral immune mechanisms and viral adaptation
Respiratory syncytial virus (RSV) vaccine recommendations for adults: a review of available global, regional, and country level recommendations
Association of the publicly funded two-dose varicella vaccine policy with varicella incidence in Shanghai: an interrupted time series study
Estimating the time required to reach HPV vaccination targets across Europe
Trends in adolescent and adult vaccination in pharmacy and medical settings in the United States, 2018–2024: a database study
Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study
Vaccination strategies for solid organ transplant candidates and recipients: insights and recommendations
TAK-003: development of a tetravalent dengue vaccine
Patterns of co-administration and sequential administration of COVID-19 and influenza vaccinations: a US study using Adheris pharmacy dataset
Virus-like particles: a versatile and effective vaccine platform
Subolesin: a 20-year path from discovery to an effective tick vaccine
Trends in co-administration of adult vaccinations in the US retail pharmacy setting
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus
A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan
Public health impact of adjuvanted RSVPreF3 vaccine in older adults: a modeling study in nine countries in Middle East and North Africa
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany
Hepatitis E vaccine landscape update 2025
Global variations in immunisation strategies against pertussis in infancy
EUVIMED